由Leishmania donovani引起的皮肤莱什曼病的诊断工具:叙述性审查
Sachee Bhanu Piyasiri1, Rajika Dewasurendra1, Nilakshi Samaranayake1
1Department of Parasitology, Faculty of Medicine, University of Colombo, Kynsey Road, Colombo 0800, Sri Lanka.
Diagnostics (Basel, Switzerland)
|September 28, 2023
概括
由Leishmania donovani引起的皮肤雷什曼病 (CL) 存在诊断挑战,特别是在斯里兰卡等地区. 本综述评估了与L. donovani相关的CL的各种诊断方法,以帮助控制工作.
科学领域:
- * 热带医学 热带医学
- * 寄生虫学 寄生虫学
- * 传染病 传染病
背景情况:
- *莱什曼病是一种被忽视的热带疾病,影响全球超过10亿人.
- * 由印度次大陆的Leishmania donovani引起的内脏莱什曼尼亚病 (VL) 是消除的目标.
- *由于L. donovani引起的皮肤雷什曼病 (CL),特别是在斯里兰卡,由于异常呈现,对消除努力构成挑战.
研究的目的:
- *审查和评估由Leishmania donovani引起的皮肤莱什曼尼病 (CL) 的诊断方法.
- *评估临床,显微,分子和免疫诊断方法的准确性,可行性和相关性.
- *讨论诊断L. donovani相关的CL的挑战,并探索新的诊断策略.
主要方法:
- * 对莱什马尼亚donovani相关的皮肤莱什马尼亚病的诊断方法的综合文献综述.
- *评估斯里兰卡和其他旧世界地区的证据.
- *对临床,显微镜,分子和免疫学诊断工具的评估.
主要成果:
- * 对于与Leishmania donovani相关的CL存在各种诊断方法,每个方法的准确性和可行性各不相同.
- * 非典型的L. donovani相关的CL呈现使诊断复杂化,并对控制构成挑战.
- *新型诊断方法显示出改善CL检测的希望.
结论:
- *准确和可行的诊断工具对于控制和消除与Leishmania donovani相关的皮肤雷什曼病至关重要.
- * 解决诊断复杂性,特别是非典型的表型,对于成功的公共卫生干预至关重要.
- * 需要对新型诊断方法的持续研究,以提高CL的检测和管理.
关键词:
莱什曼尼亚的捐赠人皮肤上的莱什曼病.诊断的准确性 诊断的准确性直接的聚合方式.组织病理学 组织病理学免疫学诊断 免疫学诊断 免疫学诊断显微镜 显微镜是指使用显微镜.分子诊断 分子诊断 分子诊断皮肤病变 皮肤病变更多相关视频
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
22.5K
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.3K
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
